Mingcai Li

Dr. Mingcai Li

orcid

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2012 in Journal of Neuroimmunology
Verified
Journal Article
Closed access
MLMingcai Li
Mingcai Li
YLYan Li
Yan Li
XLXiaojin Liu
Xiaojin Liu
XGXueming Gao
Xueming Gao
YWYaqing Wang
Yaqing Wang

1 January 2015 in Mediators of Inflammation
Verified
Journal Article
Open access
PDF file
XYXianli Yuan
Xianli Yuan
XPXiao Peng
Xiao Peng
YLYan Li
Yan Li
MLMingcai Li
Mingcai Li
Interleukin‐ (IL‐) 38 is a recently discovered cytokine and is the tenth member of the IL‐1 cytokine family. IL‐38 shares structural features with IL‐1 receptor antagonist (IL‐1Ra) and IL‐36Ra. IL‐36R is the specific receptor of IL‐38, a partial receptor antagonist of IL‐36. IL‐38 inhibits the production of T‐cell cytokines IL‐17 and IL‐22. IL‐38 also inhibits the production of IL‐8 induced by IL‐36γ, thus inhibiting inflammatory responses. IL‐38‐related cytokines, including IL‐1Ra and IL‐36Ra, are involved in the regulation of inflammation and immune responses. The study of IL‐38 and IL‐38‐related cytokines might provide new insights for developing anti‐inflammatory treatments in the near future.

18 October 2012 in Immunology
Verified
Journal Article
Open access
PDF file
CQChuan Qiu
Chuan Qiu
YLYan Li
Yan Li
MLMingcai Li
Mingcai Li
MLMin Li
Min Li
XLXiaojin Liu
Xiaojin Liu
DXDamo Xu
Damo Xu
Summary: The mechanism by which cigarette smoke (CS) causes chronic obstructive pulmonary disease (COPD) is poorly understood. Interleukin‐33 (IL‐33) is a pleiotropic cytokine predominantly expressed in lung tissue and can elicit airway inflammation in naive mice. We tested the hypothesis that IL‐33 is induced by CS and contributes to CS‐mediated airway inflammation in a mouse model of CS‐induced COPD. Groups of mice were exposed to CS three times per day for 4 consecutive days. The expression levels of IL‐33 and ST2 were markedly enhanced in the lung tissue of mice inhaling CS. Exposure to CS also induced neutrophil and macrophage infiltration and expression of inflammatory cytokines (IL‐1β, tumour necrosis factor‐α, IL‐17), chemokines (monocyte chemoattractant protein‐1) and mucin 5, subtypes A and C in the airways. More importantly, all of these CS‐induced pathogenic changes were significantly inhibited by treatment with neutralizing anti‐IL‐33 antibody delivered intranasally. Hence, our results suggest that IL‐33 plays a critical role in CS‐mediated airway inflammation and may be a therapeutic target in CS‐related diseases, including COPD.

27 July 2020 in Central European Journal of Immunology
Verified
Journal Article
Open access
ZLZhiyu Lu
Zhiyu Lu
KXKeye Xu
Keye Xu
XWXiaoying Wang
Xiaoying Wang
YLYan Li
Yan Li
MLMingcai Li
Mingcai Li
Interleukin (IL)-12 family member is a heterodimer glycoprotein, composed of two covalently linked subunits, a and b chains. The a subunit consists of IL-23p19, IL-27p28, and IL-12p35, and the b subunit includes IL-12p40 and Epstein-Barr virus-induced gene (Ebi3). IL-39 is a new heterodimeric IL-12 family member composed of IL-23p19 and Ebi3 subunits. IL-39 is secreted by lipopolysaccharide-stimulated B cells. Other immune cells, such as dendritic cells and macrophages, express IL-39 mRNA. In lupus-like mice, GL7+B cells and CD138+plasma cells are highly activated and widely expressed, promoting high expression of IL-39. IL-39 mediates inflammatory responses through binding to a heterodimer of IL-23R/gp130 receptor and activation of signal transducer and activator of transcription (STAT)1/STAT3 signal molecules. The serum levels of IL-39 were significantly increased in patients with acute coronary syndrome compared with patients with normal coronary arteries. This review discusses the biological characteristics, receptor, and signal pathway as well as biological activity of IL-39 and its potential role in inflammation and other diseases.

16 April 2015 in Journal of Leukocyte Biology
Verified
Journal Article
Closed access
PDF file
QGQiaoyan Gao
Qiaoyan Gao
YLYan Li
Yan Li
MLMingcai Li
Mingcai Li
IL-33, a new member of the IL-1F, is widely expressed throughout the body and can be up-regulated by stimulation with proinflammatory factors. It has been identified as a functional ligand for the plasma membrane receptor complex that is a heterodimer consisting of membrane-bound ST2L, which is a member of the IL-1R family, and IL-1RAcP. IL-33 is crucial for the induction of Th2 immune responses. Additionally, under other circumstances, it can also act as an endogenous danger signal. Recently, many studies have demonstrated that IL-33 may be related to the development and progression of fibrotic diseases. It has proinflammatory effects in some fibrotic diseases but has anti-inflammatory effects in others. In this review, the biologic characteristics of IL-33 and the role of the IL-33/ST2 signaling pathway in various fibrotic diseases will be discussed. We hope this overview will provide new insights for the treatment of these diseases.

7 October 2016 in International Immunopharmacology
Verified
Journal Article
Closed access
XYXianli Yuan
Xianli Yuan
YLYan Li
Yan Li
XPXiuhe Pan
Xiuhe Pan
XPXiao Peng
Xiao Peng
GSGaihuan Song
Gaihuan Song
MLMingcai Li
Mingcai Li